Janus Henderson Group PLC Agenus Inc Transaction History

Janus Henderson Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.63 - $1.14 $193 - $349	-307 Reduced 0.6%	50,815 $42,000
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $275 - $462	246 Added 0.48%	51,122 $57,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $45 - $71	35 Added 0.07%	50,876 $81,000
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $25,225 - $51,321	17,397 Added 52.02%	50,841 $77,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $4 - $6	2 Added 0.01%	33,444 $80,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $215 - $345	110 Added 0.33%	33,442 $68,000
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $113 - $229	87 Added 0.26%	33,332 $65,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $368 - $544	157 Added 0.47%	33,245 $82,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $96,616 - $189,925	33,088 New	33,088 $107,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.